39516-21-7

Basic information

• Product Name: Tiopropamine
• Synonyms: Tiopropamine;thiopropamine;3,3-Diphenyl-3'-(phenylthio)dipropylamine;3,3-Diphenylpropyl-3-(phenylthio)propylamine;1-(thiophen-2-yl)-2-aminopropane
• CAS NO: 39516-21-7
• Molecular Formula: C₂₄H₂₇NS
• Molecular Weight: 361.54
• Mol File: 39516-21-7.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 520.4°Cat760mmHg
• Flash Point: 268.5°C
• Appearance: /
• Density: 1.09g/cm³
• Vapor Pressure: 6.25E-11mmHg at 25°C
• Refractive Index: 1.618
• PKA: 10.02±0.19(Predicted)
• CAS DataBase Reference: Tiopropamine(CAS DataBase Reference)
• NIST Chemistry Reference: Tiopropamine(39516-21-7)
• EPA Substance Registry System: Tiopropamine(39516-21-7)

Safety Data

• Hazardous Substances Data: 39516-21-7(Hazardous Substances Data)

Usage

Description

Tiopropamine, also known as thioctic amine, is a psychoactive stimulant drug with a structure similar to amphetamine. It acts as a dopamine and norepinephrine reuptake inhibitor, increasing the levels of these neurotransmitters in the brain. Tiopropamine has potential medical applications but is also a potent psychoactive substance with significant risks, requiring caution and medical supervision.

Uses

Used in Pharmaceutical Industry:
Tiopropamine is used as a potential treatment for attention deficit hyperactivity disorder (ADHD) due to its ability to increase dopamine and norepinephrine levels in the brain, which can help improve focus and reduce hyperactivity.
Tiopropamine is also used as a potential treatment for narcolepsy, a sleep disorder characterized by excessive daytime sleepiness and sudden episodes of muscle weakness. Its stimulant effects can help promote wakefulness and reduce the frequency of sleep attacks.
However, it is important to note that Tiopropamine is not approved for medical use in most countries and is classified as a controlled substance due to its potential for abuse and addiction. Its use should be strictly regulated and monitored under medical supervision to minimize the risks associated with its psychoactive properties.

InChI:InChI=1/C24H27NS/c1-4-11-21(12-5-1)24(22-13-6-2-7-14-22)17-19-25-18-10-20-26-23-15-8-3-9-16-23/h1-9,11-16,24-25H,10,17-20H2